212 related articles for article (PubMed ID: 2545303)
1. Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system.
Dilts RP; Kalivas PW
Brain Res; 1989 May; 488(1-2):311-27. PubMed ID: 2545303
[TBL] [Abstract][Full Text] [Related]
2. Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens.
Churchill L; Dilts RP; Kalivas PW
Brain Res; 1990 Mar; 511(1):41-54. PubMed ID: 2158856
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE).
Dilts RP; Kalivas PW
Synapse; 1990; 6(2):121-32. PubMed ID: 1978419
[TBL] [Abstract][Full Text] [Related]
4. Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions.
Unterwald EM; Tempel A; Koob GF; Zukin RS
Brain Res; 1989 Dec; 505(1):111-8. PubMed ID: 2558779
[TBL] [Abstract][Full Text] [Related]
5. Multiple heteroreceptors on limbic thalamic axons: M2 acetylcholine, serotonin1B, beta 2-adrenoceptors, mu-opioid, and neurotensin.
Vogt BA; Crino PB; Jensen EL
Synapse; 1992 Jan; 10(1):44-53. PubMed ID: 1311129
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.
Herve D; Tassin JP; Studler JM; Dana C; Kitabgi P; Vincent JP; Glowinski J; Rostene W
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6203-7. PubMed ID: 3016745
[TBL] [Abstract][Full Text] [Related]
7. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
Churchill L; Kalivas PW
Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
[TBL] [Abstract][Full Text] [Related]
8. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
Latimer LG; Duffy P; Kalivas PW
J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
[TBL] [Abstract][Full Text] [Related]
9. Facilitatory modulation of mesolimbic dopamine neuronal activity by a mu-opioid agonist and nicotine as examined with in vivo microdialysis.
Yoshida M; Yokoo H; Tanaka T; Mizoguchi K; Emoto H; Ishii H; Tanaka M
Brain Res; 1993 Oct; 624(1-2):277-80. PubMed ID: 8252400
[TBL] [Abstract][Full Text] [Related]
10. Neutral endopeptidase-24.11, mu and delta opioid receptors after selective brain lesions: an autoradiographic study.
Waksman G; Hamel E; Delay-Goyet P; Roques BP
Brain Res; 1987 Dec; 436(2):205-16. PubMed ID: 2829989
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of endogenous or exogenous (mu, delta) opioid peptides: relation with DA mesolimbic pathways.
Calenco-Choukroun G; Daugé V; Féger J; Roques BP
Prog Clin Biol Res; 1990; 328():417-20. PubMed ID: 2154801
[No Abstract] [Full Text] [Related]
12. Lesion of dopamine mesolimbic neurons blocks behavioral effects induced by the endogenous enkephalins but not by a mu-opioid receptor agonist.
Calenco-Choukroun G; Daugé V; Gacel G; Roques BP
Eur J Pharmacol; 1991 Dec; 209(3):267-71. PubMed ID: 1665799
[TBL] [Abstract][Full Text] [Related]
13. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
Smith JA; Leslie FM; Broide RS; Loughlin SE
Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of enkephalin metabolism and activation of mu- or delta-opioid receptors elicit opposite effects on reward and motility in the ventral mesencephalon.
Heidbreder C; Gewiss M; Lallemand S; Roques BP; De Witte P
Neuropharmacology; 1992 Mar; 31(3):293-8. PubMed ID: 1321359
[TBL] [Abstract][Full Text] [Related]
15. Bilateral modulation of [3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study.
Cadet JL; Kujirai K; Przedborski S
Brain Res; 1991 Nov; 564(1):37-44. PubMed ID: 1663814
[TBL] [Abstract][Full Text] [Related]
16. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
Quirion R; Chiueh CC; Everist HD; Pert A
Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
[TBL] [Abstract][Full Text] [Related]
17. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel R; Herz A; Shippenberg TS
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2046-50. PubMed ID: 1347943
[TBL] [Abstract][Full Text] [Related]
18. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.
Bals-Kubik R; Ableitner A; Herz A; Shippenberg TS
J Pharmacol Exp Ther; 1993 Jan; 264(1):489-95. PubMed ID: 8093731
[TBL] [Abstract][Full Text] [Related]
19. Limbic thalamus in rabbit: architecture, projections to cingulate cortex and distribution of muscarinic acetylcholine, GABAA, and opioid receptors.
Vogt LJ; Vogt BA; Sikes RW
J Comp Neurol; 1992 May; 319(2):205-17. PubMed ID: 1326004
[TBL] [Abstract][Full Text] [Related]
20. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
